Friday 6 November 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue: +5.93%
EPS: +23.1%
Free cash flow: −9.79%
Total debt: −38.9%

Quarter to September 2026, against a year earlier

232.72 6.59 −2.75%

Follow RMD

Alert me

Market cap: $33.7B
P/E: 21.7×
Fwd P/E: 19.6×
Dividend yield: 1.03%
F-score: 6/9
Altman Z: 10.00
Beneish M: −2.59
Dividend safety: 96/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

ResMed Inc. 10-Q filed Oct 30, 2026

Fiscal Q1 2027 · Period ended Sep 30, 2026 · Filed Oct 30, 2026 · accepted 6:11 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors: no material changes, the filing says; every paragraph is new since the annual report